Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus.
Persistent differences in blood glucose and serum glycosylated hemoglobin (HbA1C) measurements were observed in 4 human immunodeficiency virus-positive patients with diabetes mellitus, all of whom were taking drugs associated with hemolysis, which interferes with the reliability of HbA1C levels. Determination of fructosamine levels was a more accurate alternative for measuring average glycemic control in these patients.
Polgreen
Philip M
PM
Department of Internal Medicine and Research, Iowa City Veterans Administration Medical Center and University of Iowa, Iowa City, IA, USA. Philip-Polgreen@uiowa.edu
Putz
Darcy
D
Stapleton
Jack T
JT
D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood*; D019270:Fructosamine / Q000378:metabolism; D006442:Glycated Hemoglobin / Q000378:metabolism*; D015658:HIV Infections / Q000150:complications*; D006679:HIV Seropositivity; D006801:Humans; D008297:Male; D008875:Middle Aged
D001786:Blood Glucose; D019270:Fructosamine; D006442:Glycated Hemoglobin